Canopy Growth: Don't Punish This Pot Stock – Seeking Alpha

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Leave a comment

Pot Stocks Are Getting Crushed Along With the Rest of the Market –

Shares of the biggest cannabis players are falling in conjunction with the wider market Monday. The Dow Jones Industrial Average dropped 1.56%, or 396 points, while the Nasdaq fell deeper into correction territory, falling 3.03% on the day, and the S&P 500 declined 1.66%. 

Cannabis was not immune from the selloff.

Canada, which recently legalized non medical adult-use cannabis, is expected to generate up to $7.17 billion in total sales in 2019, according to a recent Deloitte report. 

But a spate of disappointing earnings last week has some investors reevaluating the immediate viability of some of the biggest names in cannabis. Here’s how pot stocks are doing today. 

DAVIDsTEA Inc. (DTEA) fell 2.9%. 

Cronos Group Inc. (CRON) declined 3.74%.

India Globalization Capital Inc. (IGCC) dropped 7.08%. 

Tilray Inc. (TLRY) fell 3.36%. 

Canopy Growth Corp. (CGC) declined 7%. 

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Leave a comment

Pot Stocks To Ponder – Nasdaq

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Leave a comment

Is Tilray an overvalued marijuana stock, or is there room for growth? – PotNetwork

Earnings report season proved disappointing for most major cannabis companies, with Cronos Group being one of the few bright spots. For such a talked-about stock, Tilray, in particular, put up unimpressive financial results, with the company reporting last week that they missed earnings estimates for the second time in for the third quarter and nine months that ended September 30, 2018.

Following the after-hours earnings announcement Tuesday, Tilray stock opened down Wednesday to $105.56 from the previous day’s $111.17 close, a 5 percent decline. The stock continued inching down Wednesday to $102.34 at close, which resulted in a total decline from prior days’ close of around 8 percent.

[WeedMD acquires cannabis sales license from Health Canada]

Since then, the stock has made somewhat of a comeback with the returns in the last five trading sessions remaining relatively flat.

“The cannabis industry remains very robust and we are pleased with our revenue momentum and strategic achievements in the third quarter,” said Brendan Kennedy, President and Chief Executive Officer of Tilray in a statement. “We are in the early stages of achieving our growth potential and our team continues to strategically execute on disciplined operational initiatives and investments to support Tilray’s long-term, sustainable growth as the pace of legalization continues to accelerate around the world.”

“Going forward, the demand for our products is strong and we remain committed to expanding our leadership in the global medical and adult-use cannabis markets,” he continued.

Tilray is overvalued, but analysts continue to consider it a buy

Tilray made history when it became the first marijuana stock IPO on a United States exchange. While shares took investors on a rollercoaster ride all summer and into the fall, ranging from the $17 IPO price to $300 momentarily back

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Leave a comment

This Innovative Marijuana Stock's Making a Big Move – Motley Fool

There’s a lot of investor demand for marijuana stocks right now. Because of the recent opening of the Canadian recreational cannabis market along with a rising number of U.S. states and other jurisdictions worldwide legalizing pot, companies that grow marijuana have vaulted into the limelight. The desire to be able to invest in cannabis has pushed many companies to look at initial public offerings, both in Canada and on U.S. stock exchanges.

It might seem like marijuana growers are essentially identical, with all sharing in rising demand for their products. Yet that’s actually not the case, as some companies have taken innovative approaches toward cultivating and harvesting cannabis that investors hope will result in better yields and lower costs. That’s the primary appeal of CannTrust Holdings (NASDAQOTH:CNTTF), and soon, U.S. investors will get an opportunity to buy shares of the Canadian cultivator on the New York Stock Exchange.

Image source: CannTrust.

What makes CannTrust stand out?

On its face, CannTrust Holdings looks like just about any other marijuana company. The Canadian cannabis producer, headquartered in the Toronto suburb of Vaughan, got started as a specialist in providing medical marijuana products to patients. The company has two primary growing facilities, one in Vaughan and the other in the Niagara region across the border from Buffalo. With the recent legalization of recreational cannabis products, CannTrust has expanded its scope to serve the adult-use market as well.

CannTrust is far from the only company to get started with medical cannabis, but there are several ways in which it distinguishes itself from its competitors. First is the fact that although the company just began operating less than five years ago, its founders were pharmacists, bringing more than 40 years of experience in the broader pharmacy and healthcare fields to the table. That brought a

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Leave a comment
« Older